Browsing: Dable

Atavistik Bio has appointed biopharmaceutical executive Habib Dable to its board of directors, adding a veteran leader in drug development and commercialization as the Cambridge, Massachusetts-based clinical-stage biotechnology company advances its lead rare disease program and prepares for its next phase of growth in rare hematology